Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Juana Castaneda"'
Autor:
Leoni A. Kunz-Schughart, Reinhard Ebner, Juergen Friedrich, Markus Doss, Wolfgang Eder, Juana Castaneda, Elisabeth Huber
Publikováno v:
SLAS Discovery. 12:925-937
Cell-based assays are more complex than cell-free test systems but still reflect a highly artificial cellular environment. Incorporation of organotypic 3-dimensional (3-D) culture systems into mainstream drug development processes is increasingly dis
Autor:
Chad Morris, Ricardo Cibotti, Ronald Herbst, Bo Chen, Anna Glodek, Anthony J. Coyle, Laurent P. Audoly, Juana Castaneda, Gary P. Sims, Stephen Horrigan, Derong Liu, Peter A. Kiener, Dan Soppet, Qin Zong, Brian Naiman
Publikováno v:
Molecular medicine (Cambridge, Mass.). 14(7-8)
Multiple lines of evidence suggest that inhibition of Type I Interferons, including IFN-alpha, may provide a therapeutic benefit for autoimmune diseases. Using a chemical genomics approach integrated with cellular and in vivo assays, we screened a sm
Autor:
Bo Chen, Ricardo Cibotti, Qin Zong, Chad Morris, Juana Castaneda, Brian Naiman, Derong Liu, Anna Glodek, Dan Soppet, Steve Horrigan, Peter Kiener, Anthony Coyle, Laurent Audoly
Publikováno v:
The Journal of Immunology. 178:S240-S240
Multiple lines of evidence suggest that inhibition of Type I Interferons (IFNs), including IFN(, may provide a therapeutic benefit in treating a number of autoimmune diseases such as Systemic Lupus Erythematosus (SLE). Herein, we describe the generat